血液抗凝固剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Blood Anticoagulant Market Insights, Forecast to 2028

• レポートコード：QY2207E10344 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の血液抗凝固剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に血液抗凝固剤の世界市場のxxx％を占める「経口剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の血液抗凝固剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの血液抗凝固剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの血液抗凝固剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 血液抗凝固剤のグローバル主要メーカーには、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 血液抗凝固剤市場は、種類と用途によって区分されます。世界の血液抗凝固剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口剤、注射剤 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 血液抗凝固剤製品概要 - 種類別市場（経口剤、注射剤） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の血液抗凝固剤販売量予測2017-2028 - 世界の血液抗凝固剤売上予測2017-2028 - 血液抗凝固剤の地域別販売量 - 血液抗凝固剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別血液抗凝固剤販売量 - 主要メーカー別血液抗凝固剤売上 - 主要メーカー別血液抗凝固剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口剤、注射剤） - 血液抗凝固剤の種類別販売量 - 血液抗凝固剤の種類別売上 - 血液抗凝固剤の種類別価格 ・用途別市場規模（病院、診療所、その他） - 血液抗凝固剤の用途別販売量 - 血液抗凝固剤の用途別売上 - 血液抗凝固剤の用途別価格 ・北米市場 - 北米の血液抗凝固剤市場規模（種類別、用途別） - 主要国別の血液抗凝固剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの血液抗凝固剤市場規模（種類別、用途別） - 主要国別の血液抗凝固剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の血液抗凝固剤市場規模（種類別、用途別） - 主要国別の血液抗凝固剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の血液抗凝固剤市場規模（種類別、用途別） - 主要国別の血液抗凝固剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの血液抗凝固剤市場規模（種類別、用途別） - 主要国別の血液抗凝固剤市場規模（トルコ、サウジアラビア） ・企業情報 Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticals ・産業チェーン及び販売チャネル分析 - 血液抗凝固剤の産業チェーン分析 - 血液抗凝固剤の原材料 - 血液抗凝固剤の生産プロセス - 血液抗凝固剤の販売及びマーケティング - 血液抗凝固剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 血液抗凝固剤の産業動向 - 血液抗凝固剤のマーケットドライバー - 血液抗凝固剤の課題 - 血液抗凝固剤の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Blood Anticoagulant Market
Due to the COVID-19 pandemic, the global Blood Anticoagulant market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the Blood Anticoagulant global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Blood Anticoagulant market size is valued at US$ million in 2021, while the US and Europe Blood Anticoagulant are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Blood Anticoagulant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Blood Anticoagulant include Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Johnson & Johnson, Sanofi, AstraZeneca and Eli Lilly and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Blood Anticoagulant Scope and Segment
Blood Anticoagulant market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Blood Anticoagulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Clinic
Others
By Company
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Blood Anticoagulant Product Introduction
1.2 Market by Type
1.2.1 Global Blood Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Blood Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Blood Anticoagulant Sales Estimates and Forecasts 2017-2028
2.2 Global Blood Anticoagulant Revenue Estimates and Forecasts 2017-2028
2.3 Global Blood Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Blood Anticoagulant Sales by Region
2.4.1 Global Blood Anticoagulant Sales by Region (2017-2022)
2.4.2 Global Sales Blood Anticoagulant by Region (2023-2028)
2.5 Global Blood Anticoagulant Revenue by Region
2.5.1 Global Blood Anticoagulant Revenue by Region (2017-2022)
2.5.2 Global Blood Anticoagulant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Blood Anticoagulant Sales by Manufacturers
3.1.1 Global Top Blood Anticoagulant Manufacturers by Sales (2017-2022)
3.1.2 Global Blood Anticoagulant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blood Anticoagulant in 2021
3.2 Global Blood Anticoagulant Revenue by Manufacturers
3.2.1 Global Blood Anticoagulant Revenue by Manufacturers (2017-2022)
3.2.2 Global Blood Anticoagulant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Blood Anticoagulant Revenue in 2021
3.3 Global Blood Anticoagulant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Blood Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Blood Anticoagulant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Blood Anticoagulant Sales by Type
4.1.1 Global Blood Anticoagulant Historical Sales by Type (2017-2022)
4.1.2 Global Blood Anticoagulant Forecasted Sales by Type (2023-2028)
4.1.3 Global Blood Anticoagulant Sales Market Share by Type (2017-2028)
4.2 Global Blood Anticoagulant Revenue by Type
4.2.1 Global Blood Anticoagulant Historical Revenue by Type (2017-2022)
4.2.2 Global Blood Anticoagulant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Blood Anticoagulant Revenue Market Share by Type (2017-2028)
4.3 Global Blood Anticoagulant Price by Type
4.3.1 Global Blood Anticoagulant Price by Type (2017-2022)
4.3.2 Global Blood Anticoagulant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Blood Anticoagulant Sales by Application
5.1.1 Global Blood Anticoagulant Historical Sales by Application (2017-2022)
5.1.2 Global Blood Anticoagulant Forecasted Sales by Application (2023-2028)
5.1.3 Global Blood Anticoagulant Sales Market Share by Application (2017-2028)
5.2 Global Blood Anticoagulant Revenue by Application
5.2.1 Global Blood Anticoagulant Historical Revenue by Application (2017-2022)
5.2.2 Global Blood Anticoagulant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Blood Anticoagulant Revenue Market Share by Application (2017-2028)
5.3 Global Blood Anticoagulant Price by Application
5.3.1 Global Blood Anticoagulant Price by Application (2017-2022)
5.3.2 Global Blood Anticoagulant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Blood Anticoagulant Market Size by Type
6.1.1 North America Blood Anticoagulant Sales by Type (2017-2028)
6.1.2 North America Blood Anticoagulant Revenue by Type (2017-2028)
6.2 North America Blood Anticoagulant Market Size by Application
6.2.1 North America Blood Anticoagulant Sales by Application (2017-2028)
6.2.2 North America Blood Anticoagulant Revenue by Application (2017-2028)
6.3 North America Blood Anticoagulant Market Size by Country
6.3.1 North America Blood Anticoagulant Sales by Country (2017-2028)
6.3.2 North America Blood Anticoagulant Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Blood Anticoagulant Market Size by Type
7.1.1 Europe Blood Anticoagulant Sales by Type (2017-2028)
7.1.2 Europe Blood Anticoagulant Revenue by Type (2017-2028)
7.2 Europe Blood Anticoagulant Market Size by Application
7.2.1 Europe Blood Anticoagulant Sales by Application (2017-2028)
7.2.2 Europe Blood Anticoagulant Revenue by Application (2017-2028)
7.3 Europe Blood Anticoagulant Market Size by Country
7.3.1 Europe Blood Anticoagulant Sales by Country (2017-2028)
7.3.2 Europe Blood Anticoagulant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Blood Anticoagulant Market Size by Type
8.1.1 Asia Pacific Blood Anticoagulant Sales by Type (2017-2028)
8.1.2 Asia Pacific Blood Anticoagulant Revenue by Type (2017-2028)
8.2 Asia Pacific Blood Anticoagulant Market Size by Application
8.2.1 Asia Pacific Blood Anticoagulant Sales by Application (2017-2028)
8.2.2 Asia Pacific Blood Anticoagulant Revenue by Application (2017-2028)
8.3 Asia Pacific Blood Anticoagulant Market Size by Region
8.3.1 Asia Pacific Blood Anticoagulant Sales by Region (2017-2028)
8.3.2 Asia Pacific Blood Anticoagulant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Blood Anticoagulant Market Size by Type
9.1.1 Latin America Blood Anticoagulant Sales by Type (2017-2028)
9.1.2 Latin America Blood Anticoagulant Revenue by Type (2017-2028)
9.2 Latin America Blood Anticoagulant Market Size by Application
9.2.1 Latin America Blood Anticoagulant Sales by Application (2017-2028)
9.2.2 Latin America Blood Anticoagulant Revenue by Application (2017-2028)
9.3 Latin America Blood Anticoagulant Market Size by Country
9.3.1 Latin America Blood Anticoagulant Sales by Country (2017-2028)
9.3.2 Latin America Blood Anticoagulant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Blood Anticoagulant Market Size by Type
10.1.1 Middle East and Africa Blood Anticoagulant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Blood Anticoagulant Revenue by Type (2017-2028)
10.2 Middle East and Africa Blood Anticoagulant Market Size by Application
10.2.1 Middle East and Africa Blood Anticoagulant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Blood Anticoagulant Revenue by Application (2017-2028)
10.3 Middle East and Africa Blood Anticoagulant Market Size by Country
10.3.1 Middle East and Africa Blood Anticoagulant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Blood Anticoagulant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boehringer Ingelheim Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Overview
11.4.3 Daiichi Sankyo Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Daiichi Sankyo Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daiichi Sankyo Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Keryx Biopharmaceuticals
11.10.1 Keryx Biopharmaceuticals Corporation Information
11.10.2 Keryx Biopharmaceuticals Overview
11.10.3 Keryx Biopharmaceuticals Blood Anticoagulant Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Keryx Biopharmaceuticals Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Keryx Biopharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Blood Anticoagulant Industry Chain Analysis
12.2 Blood Anticoagulant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood Anticoagulant Production Mode & Process
12.4 Blood Anticoagulant Sales and Marketing
12.4.1 Blood Anticoagulant Sales Channels
12.4.2 Blood Anticoagulant Distributors
12.5 Blood Anticoagulant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Blood Anticoagulant Industry Trends
13.2 Blood Anticoagulant Market Drivers
13.3 Blood Anticoagulant Market Challenges
13.4 Blood Anticoagulant Market Restraints
14 Key Findings in The Global Blood Anticoagulant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Blood Anticoagulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injection
Table 4. Global Blood Anticoagulant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Blood Anticoagulant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Blood Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 7. Global Blood Anticoagulant Sales Market Share by Region (2017-2022)
Table 8. Global Blood Anticoagulant Sales by Region (2023-2028) & (K Units)
Table 9. Global Blood Anticoagulant Sales Market Share by Region (2023-2028)
Table 10. Global Blood Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Blood Anticoagulant Revenue Market Share by Region (2017-2022)
Table 12. Global Blood Anticoagulant Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Blood Anticoagulant Revenue Market Share by Region (2023-2028)
Table 14. Global Blood Anticoagulant Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Blood Anticoagulant Sales Share by Manufacturers (2017-2022)
Table 16. Global Blood Anticoagulant Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Blood Anticoagulant Revenue Share by Manufacturers (2017-2022)
Table 18. Blood Anticoagulant Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Blood Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Blood Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Anticoagulant as of 2021)
Table 21. Blood Anticoagulant Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Blood Anticoagulant Product Offered
Table 23. Date of Manufacturers Enter into Blood Anticoagulant Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 26. Global Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 27. Global Blood Anticoagulant Sales Share by Type (2017-2022)
Table 28. Global Blood Anticoagulant Sales Share by Type (2023-2028)
Table 29. Global Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Blood Anticoagulant Revenue Share by Type (2017-2022)
Table 32. Global Blood Anticoagulant Revenue Share by Type (2023-2028)
Table 33. Blood Anticoagulant Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Blood Anticoagulant Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 36. Global Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 37. Global Blood Anticoagulant Sales Share by Application (2017-2022)
Table 38. Global Blood Anticoagulant Sales Share by Application (2023-2028)
Table 39. Global Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Blood Anticoagulant Revenue Share by Application (2017-2022)
Table 42. Global Blood Anticoagulant Revenue Share by Application (2023-2028)
Table 43. Blood Anticoagulant Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Blood Anticoagulant Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 46. North America Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 47. North America Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 50. North America Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 51. North America Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 54. North America Blood Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 55. North America Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Blood Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 58. Europe Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 59. Europe Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 62. Europe Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 63. Europe Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 66. Europe Blood Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 67. Europe Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Blood Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Blood Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Blood Anticoagulant Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Blood Anticoagulant Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Blood Anticoagulant Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Blood Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Blood Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Blood Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Blood Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Blood Anticoagulant Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Blood Anticoagulant Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Blood Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Blood Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Blood Anticoagulant Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Blood Anticoagulant Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Blood Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Blood Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Blood Anticoagulant Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Blood Anticoagulant Revenue by Country (2023-2028) & (US$ Million)
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Major Businesses
Table 107. Bayer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Bayer Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Bayer Recent Developments
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Major Businesses
Table 112. Boehringer Ingelheim Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Boehringer Ingelheim Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Boehringer Ingelheim Recent Developments
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Major Businesses
Table 117. Bristol-Myers Squibb Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Bristol-Myers Squibb Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bristol-Myers Squibb Recent Developments
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Major Businesses
Table 122. Daiichi Sankyo Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Daiichi Sankyo Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Daiichi Sankyo Recent Developments
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Pfizer Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Recent Developments
Table 130. Johnson & Johnson Corporation Information
Table 131. Johnson & Johnson Description and Major Businesses
Table 132. Johnson & Johnson Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Johnson & Johnson Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Johnson & Johnson Recent Developments
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Major Businesses
Table 137. Sanofi Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Sanofi Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sanofi Recent Developments
Table 140. AstraZeneca Corporation Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. AstraZeneca Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Description and Major Businesses
Table 147. Eli Lilly Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Eli Lilly Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Eli Lilly Recent Developments
Table 150. Keryx Biopharmaceuticals Corporation Information
Table 151. Keryx Biopharmaceuticals Description and Major Businesses
Table 152. Keryx Biopharmaceuticals Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Keryx Biopharmaceuticals Blood Anticoagulant Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Keryx Biopharmaceuticals Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Blood Anticoagulant Distributors List
Table 158. Blood Anticoagulant Customers List
Table 159. Blood Anticoagulant Market Trends
Table 160. Blood Anticoagulant Market Drivers
Table 161. Blood Anticoagulant Market Challenges
Table 162. Blood Anticoagulant Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Anticoagulant Product Picture
Figure 3. Global Blood Anticoagulant Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Blood Anticoagulant Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Blood Anticoagulant Report Years Considered
Figure 10. Global Blood Anticoagulant Sales 2017-2028 (K Units)
Figure 11. Global Blood Anticoagulant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Blood Anticoagulant Revenue 2017-2028 (US$ Million)
Figure 13. Global Blood Anticoagulant Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Blood Anticoagulant Sales Market Share by Region (2017-2022)
Figure 15. Global Blood Anticoagulant Sales Market Share by Region (2023-2028)
Figure 16. North America Blood Anticoagulant Sales YoY (2017-2028) & (K Units)
Figure 17. North America Blood Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Blood Anticoagulant Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Blood Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Blood Anticoagulant Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Blood Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Blood Anticoagulant Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Blood Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Blood Anticoagulant Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Blood Anticoagulant Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Blood Anticoagulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Blood Anticoagulant in the World: Market Share by Blood Anticoagulant Revenue in 2021
Figure 28. Global Blood Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 30. Global Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 31. Global Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 32. Global Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 33. North America Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 34. North America Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 35. North America Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 36. North America Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 37. North America Blood Anticoagulant Sales Share by Country (2017-2028)
Figure 38. North America Blood Anticoagulant Revenue Share by Country (2017-2028)
Figure 39. United States Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 42. Europe Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 43. Europe Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 44. Europe Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 45. Europe Blood Anticoagulant Sales Share by Country (2017-2028)
Figure 46. Europe Blood Anticoagulant Revenue Share by Country (2017-2028)
Figure 47. Germany Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 48. France Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Blood Anticoagulant Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Blood Anticoagulant Revenue Share by Region (2017-2028)
Figure 58. China Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 61. India Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 68. Latin America Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 70. Latin America Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Blood Anticoagulant Sales Share by Country (2017-2028)
Figure 72. Latin America Blood Anticoagulant Revenue Share by Country (2017-2028)
Figure 73. Mexico Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Blood Anticoagulant Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Blood Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Blood Anticoagulant Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Blood Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Blood Anticoagulant Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Blood Anticoagulant Revenue Share by Country (2017-2028)
Figure 83. Turkey Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Blood Anticoagulant Revenue (2017-2028) & (US$ Million)
Figure 86. Blood Anticoagulant Value Chain
Figure 87. Blood Anticoagulant Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---